First slide
CytoCell fluorescence in situ hybridisation (FISH) logo.

Product summary

  • Chromosomes
    1221
  • Labels    
  • Disease focus ALL
  • Regulatory status In vitro diagnostic. This product is intended to be used on Carnoy’s solution (3:1 methanol/acetic acid) fixed haematological samples. Disease information supported by the literature and is not a reflection of the intended purpose of this product.
Cytocell Catalogue Probe Packaging With Amber Tube
Request a quote Request a sample

Probe design

Overview

Probe specification

  • TEL (ETV6), 12p13.2, Red
  • AML1 (RUNX1), 21q22.1, Green

The TEL probe mix, labelled in red, contains a probe covering a 197kb region at the telomeric end of TEL (ETV6) and a second probe that extends 170kb in a centromeric direction beyond the TEL (ETV6) gene. The AML1 (RUNX1) probe set consists of two probes labelled in green. One locates to a 156kb region centromeric to the AML1 (RUNX1) gene and covers the CLIC6 gene. The other probe covers a 169kb region in the AML1 (RUNX1) gene that includes the markers SHGC-87606 and D21S1921.

 

Probe information

The cytogenetically-cryptic t(12;21)(p13;q22) translocation between ETV6 (ets variant 6) at 12p13 and RUNX1, (RUNX family transcription factor 1) at 21q22, results in the ETV6-RUNX1 chimeric fusion gene1.

The ETV6 and RUNX1 genes both encode transcription factors; ETV6 has been shown to be required for proper transcription during haematopoiesis within the bone marrow1,2. The ETV6-RUNX1 protein converts RUNX1 to a transcriptional repressor and causes overexpression of the erythropoietin receptor (EPOR) and activation of downstream JAK-STAT signaling1.

B-lymphoblastic leukaemia/lymphomas with t(12;21)(p13;q22) translocations form a recognised disease entity according to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukaemia. This is the most common sub-group of childhood B-ALL accounting for about 25% of cases3. As the t(12;21)(p13;q22) translocation is cytogenetically-cryptic, FISH is an important diagnostic tool for this leukaemia4.

B-ALL with ETV6-RUNX1 is considered to have a favourable outcome with cure rates more than 90%3. Late relapses have been reported; these have been attributed to the presence of persistent preleukaemic clones that survived chemotherapy3,5.

ETV6 has also been shown to be deleted in some children with ALL, with loss of heterozygosity (LOH) of chromosome 12p12-13; these deletions often seen in the presence of ETV6-RUNX1 translocations6.

Product documentation

Recommended protocol for CytoCell haematology FISH

Select a protocol step to view:

Sample and slide preparation

Icon representing the sample and slide preparation stage of the fluorescence in situ hybridisation (FISH) protocol.
  • Spot the cell sample onto a glass microscope slide. Allow to dry.
  • Immerse the slide in 2x Saline Sodium Citrate (SSC) for 2 minutes at room temperature (RT) without agitation.
  • Dehydrate in an ethanol series (70%, 85% and 100%), each for 2 minutes at RT.
  • Allow to dry.

What our customers say about CytoCell probes...

Request a quote for this product

References

  1. Mullighan, The Journal of Clinical 1. Investigation 2012;122(12):3407-3415
  2. Wang et al., Genes Dev 1998;12(15):2392-2402
  3. Swerdlow et al., (eds,) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, Lyon, France, 4th edition, IARC,2017
  4. Borkhardt et al., Blood. 1997;90(2):571-577
  5. Mosad et al., Journal of Haematology & Oncology 2008;1:17
  6. Raynaud et al., Blood 1996;87(7):2891-2899